DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 2 minutes ago

HRL·Hormel Foods Corporation

$.
-. (-.%)
Pre-Market
High
$20.87
Open
$20.87
Market Cap
11.53B
52W High
$31.86
Low
$20.87
P. Close
$20.90
P/E
23.56
52W Low
$19.70
Fwd P/E
13.39
Mean Target
$25.12
Technical Score (1D)
23
SELL
News Sentiment
53
MIXED
Hormel Foods is scheduled to report earnings this Thursday, with analysts projecting a 2.5% year-on-year revenue increase. This upcoming report follows a mixed previous quarter where the company missed revenue targets, though it did beat EBITDA estimates. Given this history, the market is anticipating performance that aligns with recent trends, with a notable caution that Hormel has a pattern of missing revenue expectations. Investors will be watching to see if this quarter breaks that trend, particularly as the company navigates its current operational landscape. The focus will be on whether Hormel can meet its revenue projections and sustain its EBITDA performance, providing insight into its ability to manage costs and demand effectively in the coming trading days.
Earnings Summary
Hormel Foods Corporation is a diversified food producer and distributor with a broad portfolio of well-known brands like Hormel, Skippy, and Planters, serving retail, foodservice, and commercial channels within the Consumer Defensive sector. The company, founded in 1891 and headquartered in Austin, Minnesota, operates in the Packaged Foods industry, focusing on both refrigerated and shelf-stable items. In its most recent reported quarters, Hormel Foods experienced mixed earnings performance. For Q2 2025, the company reported EPS of $0.35 on revenue of $3.03 billion, compared to Q1 2025 where EPS was also $0.35 but revenue was $2.90 billion. Prior to this, Q4 2024 saw EPS of $0.35 against revenue of $2.99 billion, and Q3 2025 reported EPS of $0.32 on revenue of $3.19 billion. This indicates a pattern of EPS holding steady or slightly declining in recent periods, while revenue has shown some fluctuation but generally remained in a similar range. The company has missed analyst EPS estimates in Q4 2024 and Q2 2025, while beating estimates in Q3 2025, suggesting an inconsistent beat/miss pattern against analyst expectations. Looking ahead, investors will be watching for Hormel Foods' ability to drive consistent EPS growth and manage revenue fluctuations. Key will be the performance of its Retail segment and any signs of sustained margin improvement, as highlighted by recent analyst commentary. The company's ability to navigate market dynamics and deliver on strategic initiatives will be crucial for its future financial trajectory.

EPS

EstBeatMiss
$0.29$0.32$0.36$0.39$0.43Q4'24Q1'25Q2'25Q3'25Q4'25
QtrEstActual+/−
Q4'25$0.35 - -
Q3'25$0.30$0.32+6.0%
Q2'25$0.41$0.35-14.6%
Q1'25$0.34$0.35+3.3%
Q4'24$0.37$0.35-6.6%

Revenue

EstBeatMiss
$2.9B$2.9B$3.0B$3.1B$3.2BQ4'24Q1'25Q2'25Q3'25Q4'25
QtrEstActual+/−
Q4'25$3.0B - -
Q3'25 - $3.2B -
Q2'25 - $3.0B -
Q1'25 - $2.9B -
Q4'24 - $3.0B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

HRL Stock Snapshot

HRL is currently trading at $20.87, giving Hormel Foods Corporation a market cap of 11.53B and a P/E ratio of 23.6. Today's range spans $20.87–$20.87, with shares opening at $20.87 and moving down $0.03 (0.1%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 53/100.

Over the past year HRL has traded between $19.70 and $31.86 - the current price is +5.9% off the 52-week low and -34.5% from the high. 17 analysts cover the stock with a Hold consensus and a mean 12-month target of $25.12 (range $22.00–$30.00), implying upside of +20.4%.

When HRL shows a SELL (23/100) alongside neutral sentiment (53/100), the right posture for most Consumer Defensive investors is reduced exposure rather than conviction buying. Price: $20.87 (near 52-week lows). (P/E: 23.6) At 11.53B in capitalization, the structural support levels within the $19.70–$31.86 annual range are where the setup becomes reassessable - not before.

When a large-cap Consumer Defensive name with 11.53B in capitalization prints a SELL signal (23/100) alongside neutral news sentiment (53/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $20.87 (near 52-week lows in the $19.70–$31.86 range), the structural support levels are where that sponsorship question gets answered.